IPO - LUDWIG ENTERPRISES, INC.

Form Type: S-1

Filing Date: 2025-02-13

Corporate Action: Ipo

Type: New

Accession Number: 000121390025013075

Filing Summary: Ludwig Enterprises, Inc. filed a Form S-1 Registration Statement with the SEC proposing a firm commitment public offering of its Common Stock, with plans to effect a reverse stock split prior to the offering. The company intends to utilize proceeds for operational costs including equipment, marketing, staffing, and debt repayment. Ludwig has not yet produced any products for sale and aims to launch mRNA genetic testing kits by the end of Q1 2025. The reverse split is targeted to improve the stock price for compliance with listing requirements. The last reported stock price was $0.15 prior to the offering, with negligible trading volume on the OTC Pink market. The company has identified as a smaller reporting and emerging growth company, indicating it will utilize reduced reporting obligations. This offering involves significant risks, including the uncertainty of product development and market conditions.

Document Link: View Document